Sun Pharma gets nod for scheme of arrangement

15 Nov 2017 Evaluate

Sun Pharmaceutical Industries has received an approval for the Scheme of Arrangement among Sun Pharma Global FZE (indirect wholly owned subsidiary of the Company) and the company and their respective members and creditors, for demerger of unbranded generic pharmaceutical undertaking of Sun Pharma Global FZE to the Company. The Board of Directors of the Company at their meeting held on November 14, 2017, approved the same on the recommendation of the Audit Committee.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1669.20 -31.35 (-1.84%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×